Sign in
4

Changes in Ownership

Editas Medicine, Inc. Filed Acc 0001650664-26-000007

SVP, Chief Financial Officer sold 474 shares at $2.02 ($957)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Parison Amy · SVP, Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-03 Sale : show line 1 in the form 10b5-1 −474 $2.02 $957 15,434 D
Open-market sales · 474 sh · avg $2.02 · $957
Loading xslF345X05/wk-form4_1772660958.xml…